Navigation Links
BioLife Solutions Expands Scientific Advisory Board

Adds Cell Therapy Regulatory Consultant and Cryopreservation Expert

BOTHELL, Wash., Sept. 5 /PRNewswire-FirstCall/ -- BioLife Solutions, Inc. (OTC Bulletin Board: BLFS), a leading developer and marketer of proprietary hypothermic storage and cryopreservation media products for cells, tissues, and organs, today announced the expansion of its Scientific Advisory Board (SAB) with the addition of two leading experts in cell therapy quality and regulatory assurance and in cryopreservation of stem cells derived from cord blood, dental pulp, and other sources.

The new members are:

-- Scott R. Burger, MD - Principal of Advanced Cell and Gene Therapy, a

consulting firm specializing in cell, gene, and tissue-based therapies.

Dr. Burger works with clients in industry and academic centers

worldwide, providing assistance in process development and validation,

GMP/GTP manufacturing, GMP facility design and operation, regulatory

affairs, technology evaluation, and strategic analysis. He received his

M.D. from the University of Pennsylvania School of Medicine and

completed postgraduate training in Laboratory Medicine and a clinical

fellowship in Transfusion Medicine and a postdoctoral research

fellowship at Washington University in St. Louis. He serves on the USP

Cell, Gene and Tissue Therapies Expert Committee, the advisory boards

of several cell therapy biotechnology companies, and has served as

editor of the International Society for Cellular Therapy Telegraft, and

on the ISCT Executive Committee. A frequently invited speaker at

industry and academic conferences, he is the author of more than 100

scientific publications and presentations, and recipient of numerous

honors and awards.

-- Erik J. Woods, Ph.D. - Co-Founder, CEO and Laboratory Director of The

Genesis Bank, a private cord blood bank, and also Director of Genome

Resources, an anonymous donor and client depositor sperm bank. Both

laboratories are FDA registered and CLIA compliant. Dr. Woods received

his Bachelor of Arts degree in Biology from Indiana University in

Bloomington. He then went on to study cryobiology and biomedical

engineering at the Hillenbrand Biomedical Engineering Center at Purdue

University in West Lafayette, Ind., where he earned a Doctor of

Philosophy Degree. Dr. Woods then completed a Post Doctoral Fellowship

at the Herman B Wells Center for Pediatric Research at the Indiana

University School of Medicine in Indianapolis, where he developed

enhanced methods for the cryopreservation and banking of umbilical cord

blood derived stem cells. In 1997 Dr. Woods co-founded General

BioTechnology LLC, the parent company of The Genesis Bank, to apply

these techniques to practical applications. He holds two patents, has

published numerous scientific articles, reviews and book chapters, and

is a member of many professional scientific societies, including the

American Association of Blood Banks, the International Society for

Cellular Therapy, and The Cell Transplant Society. Dr. Woods is also on

the Board of Governors for the International Society for Cryobiology.

In addition to his position with The Genesis Bank, Dr. Woods is an

Adjunct Assistant Professor in the Department of Microbiology and

Immunology at the Indiana University School of Medicine.

BioLife Chairman and CEO Mike Rice commented: "We're delighted that Scott and Erik have joined our board of scientific advisors. Their expertise and experience in the cell therapy and cord blood banking industries will greatly benefit our strategic planning process, research activities, and the creation of relevant product marketing messages to reinforce the benefits of our HypoThermosol(R) and CryoStor(TM) preservation media products in these key markets."

Drs Burger and Woods join current SAB members Shelly Heimfeld, Ph.D., Director of the Cellular Therapy Laboratory at the Fred Hutchinson Cancer Research Center; Dayong Gao, Ph.D., Professor of Mechanical and Biomedical Engineering at the University of Washington; Darin Weber, Ph.D., Senior Consultant, Cell and Gene Therapies at Biologics Consulting Group; Andrew Hinson, Vice President of Clinical and Regulatory Affairs at Symphony Medical; and Lizabeth Cardwell, Principal of Compliance Consulting.

About BioLife Solutions

BioLife Solutions develops, manufactures and markets patented hypothermic storage and cryopreservation solutions for cells, tissues, and organs. The Company's proprietary HypoThermosol(R) and CryoStor(TM) platform of solutions are marketed to academic and commercial organizations involved in cell therapy, tissue engineering, cord blood banking, drug discovery, and toxicology testing. BioLife's products are serum-free and protein-free, fully defined, and are formulated to reduce or prevent preservation-induced, delayed-onset cell damage and death. BioLife's enabling technology provides academic and clinical researchers significant improvements in post-thaw cell, tissue, and organ viability and function. For more information please visit

This news release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements include any statements that relate to the intent, belief, plans or expectations of the Company or its management, or that are not a statement of historical fact. Any forward-looking statements in this news release are based on current expectations and beliefs and are subject to numerous risks and uncertainties that could cause actual results to differ materially. Some of the specific factors that could cause BioLife Solutions' actual results to differ materially are discussed in the Company's recent filings with the Securities and Exchange Commission. BioLife Solutions disclaims any obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

Media Relations: Investor Relations:

Len Hall Matt Clawson

Allen & Caron Inc. Allen & Caron Inc.

(949) 474-4300 (949) 474-4300

SOURCE BioLife Solutions, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Sample Preparation Solutions for Cellular Protein Fractionation Poster, Rev A
2. Long-Term Instrument Control and Connectivity Solutions
3. PathCheck Applied to Measurement of Protein Solutions in the SpectraMax Plus Microplate Spectrophotometer (MaxLine Application Note #26)
4. Verifying Multichannel Pipettor Performance with Standard Dispense Solutions in the SpectraMax Plus (MaxLine Application Note #28)
5. Software company enters health space with RFID solutions on hold
6. eCare Solutions, UW Milwaukee to study health web sites
7. Tech Digest - RedPrairie; Wind Lake Solutions
8. Cooper Lighting picks RedPrairie solutions
9. Ten resolutions that could produce a happy new (tech) year
10. Inacom named Microsofts favorite learning solutions partner of the year
11. Blue Cross BlueShield of South Carolina implements Esker solutions
Post Your Comments:
(Date:11/26/2015)... MUMBAI , November 26, 2015 ... --> Accutest Research ... accredited Contract Research Organization (CRO), has ... Chase Cancer Center - Temple Health ... ,     (Photo: ) ...
(Date:11/25/2015)... BRUSSELS , November 25, 2015 ... in cat and human plaque and pave the way for ... health problems in cats     ... the most commonly diagnosed health problems in cats, yet relatively ... until now. Two collaborative studies have been conducted by researchers ...
(Date:11/25/2015)... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) ... chat discussion at the Piper Jaffray 27th Annual Healthcare ... discussion is scheduled for Wednesday, December 2, at 8:00 ... replay will be available for 14 days after the ... NormartVP, Corporate Communications and Business Development , BrewLife(858) 875-8629 ...
(Date:11/24/2015)... Calif. , Nov. 24, 2015 Cepheid ... will be speaking at the following conference, and invited ... New York, NY      Tuesday, December 1, 2015 ... New York, NY      Tuesday, December 1, 2015 ... Jaffray Healthcare Conference, New York, NY ...
Breaking Biology Technology:
(Date:11/20/2015)... , November 20, 2015 ... company focused on the growing mobile commerce market and ... Gino Pereira , was recently interviewed on ... will air on this weekend on Bloomberg Europe ... America . --> NXTD ) ("NXT-ID" or ...
(Date:11/18/2015)... --> --> ... report titled  Gesture Recognition Market - Global Industry Analysis, ... to the report, the global gesture recognition market was valued at ... US$29.1 bn by 2021, at a CAGR of 20.3% ... dominated the global gesture recognition market in ...
(Date:11/17/2015)... 17, 2015 Pressure BioSciences, Inc. (OTCQB: PBIO) ... and sale of broadly enabling, pressure cycling technology ("PCT")-based ... today announced it has received gross proceeds of $745,000 ... Placement (the "Offering"), increasing the total amount raised to ... additional closings are expected in the near future. ...
Breaking Biology News(10 mins):